Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Evotec, a drug discovery and contract research firm, has agreed to acquire DeveloGen, a developer of small-molecule drugs based in Göttingen, Germany. Evotec will pay about $18 million and make future performance-related payments. Formed in 1997, DeveloGen has alliances with Boehringer Ingelheim on small-molecule diabetes treatments and with Andromeda Biotech on a synthetic peptide for diabetes. Evotec CEO Werner Lanthaler says the purchase adds to the firm’s list of high-value partnerships.
This article has been sent to the following recipient: